Tag: EMA

Understanding and Addressing Inventory Control Failures During Inspections Inventory control failures can significantly disrupt pharmaceutical operations, leading to compliance risks and operational inefficiencies. Ensuring robust inventory management not only affects…

Investigation of Ignored Excursion Trends During Distribution Qualification and Their Regulatory Implications Pharmaceutical manufacturing and quality professionals often encounter challenges during regulatory inspections, particularly regarding distribution qualifications. One critical area…

Investigation of Unqualified Supplier Change During Distribution Qualification and Its Impact on Regulatory Inspections The integrity of the pharmaceutical supply chain hinges on the rigorous qualification of suppliers throughout distribution.…

Assessing Risks from Distribution Temperature Breaches in Pharmaceutical Supply Chains In the pharmaceutical industry, distribution temperature breaches can pose significant risks to product quality and integrity during distribution qualification. Such…

Identifying and Addressing Transport Qualification Gaps During Audits In pharmaceutical manufacturing and distribution, transport qualification is critical for ensuring that products are maintained under specified conditions throughout the supply chain.…

Investigating Cold Chain Excursions Not Assessed During Audits In the pharmaceutical industry, maintaining the integrity of products during storage and transportation is non-negotiable. Cold chain excursions—deviations from designated temperature ranges—pose…